Study of irradiation effects on cytokine secretion from retrovirally-transduced tumor cells: A model for tumor vaccination

被引:0
|
作者
Matsubara, H
Tagawa, M
Gunji, Y
Takenaga, K
Sugaya, M
Urashima, T
Koide, Y
Suzuki, T
Asano, T
Ochiai, T
Isono, K
Kageyama, H
Nakamura, Y
Sakiyama, S
机构
[1] CHIBA UNIV, SCH MED, DEPT BIOCHEM, CHIBA 260, JAPAN
[2] CHIBA CANC RES INST, DIV CHEMOTHERAPY, CHUO KU, CHIBA 260, JAPAN
[3] CHIBA CANC RES INST, DIV BIOCHEM, CHUO KU, CHIBA 260, JAPAN
关键词
irradiation; cytokine; retrovirus; tumor vaccine;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have examined the effects of irradiation on the cytokine secretion from genetically modified human esophageal and gastric carcinomas. Both cell lines were transduced retrovirally to secrete interleukin-2, interleukin-6 and granulocyte-macrophage colony-stimulating factor, respectively. The metabolism of all the transduced cells was partially, inhibited by 6 Gy, and greatly inhibited by 20 Gy irradiation. Cytokine productions, however; was not affected by 6 Gy, in many cases, and continued to be detected even after 60 Gy irradiation. The analysis of the dose and time of irradiation in each cytokine producer is useful for the designing of tl!mol vaccine using cytokine gene transfer.
引用
收藏
页码:645 / 650
页数:6
相关论文
共 50 条
  • [1] Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination
    Wan, YH
    Bramson, J
    Carter, R
    Graham, F
    Gauldie, J
    HUMAN GENE THERAPY, 1997, 8 (11) : 1355 - 1363
  • [2] Recognition of Tumor Antigens by In Vitro Developed T Cells from Hematopoietic Stem Cells Retrovirally Transduced with TCR Genes
    Zhao, Yangbing
    Zheng, Zhili
    Cohen, Cyrille J.
    Rosenberg, Steven A.
    Morgan, Richard A.
    MOLECULAR THERAPY, 2006, 13 : S175 - S175
  • [3] Vaccination with retrovirally-transduced dendritic cells introduces cellular and humoral immune responses along with specific protection against prostate antigen-expressing tumors
    Liang, SB
    Hou, JWS
    Peace, DJ
    Fowler, DH
    Medin, JA
    CANCER GENE THERAPY, 2003, 10 : S34 - S35
  • [4] Development of a novel vaccination therapy against malignant gliomas utilizing cytokine gene-transduced tumor cells
    Hirakawa, K
    Wakimoto, H
    Aoyagi, M
    Hamada, H
    11TH INTERNATIONAL CONGRESS OF NEUROLOGICAL SURGERY, VOLS 1 AND 2, 1997, : 1717 - 1721
  • [5] MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells
    J Mark Sloan
    Michael H Kershaw
    Christopher E Touloukian
    Rejean Lapointe
    Paul F Robbins
    Nicholas P Restifo
    Patrick Hwu
    Cancer Gene Therapy, 2002, 9 : 946 - 950
  • [6] MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells
    Sloan, JM
    Kershaw, MH
    Touloukian, CE
    Lapointe, R
    Robbins, PF
    Restifo, NP
    Hwu, P
    CANCER GENE THERAPY, 2002, 9 (11) : 946 - 950
  • [7] MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells
    Sloan, JM
    Kershaw, M
    Lapointe, R
    Robbins, P
    Restifo, N
    Hwu, P
    FASEB JOURNAL, 2001, 15 (05): : A1202 - A1202
  • [8] Impaired in vivo tumor growth of human pancreatic carcinoma cells retrovirally transduced with GM-CSF gene
    Kimura, M
    Tagawa, M
    Yoshida, Y
    Takenouchi, T
    Takenaga, K
    Azuma, K
    Yamaguchi, T
    Saisho, H
    Sakiyama, S
    ANTICANCER RESEARCH, 1998, 18 (1A) : 165 - 170
  • [9] Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine
    Okada, H
    Giezeman-Smits, KM
    Tahara, H
    Attanucci, J
    Fellows, WK
    Lotze, MT
    Chambers, WH
    Bozik, ME
    GENE THERAPY, 1999, 6 (02) : 219 - 226
  • [10] Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine
    H Okada
    K M Giezeman-Smits
    H Tahara
    J Attanucci
    W K Fellows
    M T Lotze
    W H Chambers
    M E Bozik
    Gene Therapy, 1999, 6 : 219 - 226